How effective is autologous stem cell transplant for multiple myeloma?

The treatment uses your own blood-forming stem cells. They are collected, followed by intensive chemotherapy, and returned to help the bone marrow recover. The aim is to remove more myeloma cells after initial therapy and produce a deeper response. It is generally part of a broader treatment plan rather than a stand-alone cure.

Doctors assess effectiveness through blood and urine tests, bone-marrow assessment when needed, imaging, symptoms, and how long the disease remains controlled. A strong response is encouraging, although myeloma can return and continued monitoring remains necessary.

Your team will review kidney function, heart and lung health, infections, medicines, previous treatments, and the condition of your veins before collection. Ask how stem-cell collection, chemotherapy, hospital or clinic care, fertility, vaccines, and infection precautions fit your circumstances. After transplant, attend scheduled blood tests and report new symptoms promptly. Maintenance treatment may be discussed to help keep myeloma controlled.

Contact your transplant team urgently for fever, chills, breathlessness, chest pain, confusion, uncontrolled vomiting, severe diarrhoea, bleeding, or difficulty drinking. During recovery, a new infection can worsen quickly because blood counts may be low. Use the emergency service for severe breathing difficulty, collapse, or heavy bleeding.

Ask which response has been reached so far, what benefit transplant is expected to add, how your personal health affects eligibility, what support is available during recovery, and how relapse monitoring and maintenance treatment will work.